P/E ratio for Harrow Health (HROW)
P/E ratio as of April 2025 (TTM): -43.0
According to Harrow Health's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -43.0179. At the end of 2022 the company had a P/E ratio of -28.4.
P/E ratio history for Harrow Health from 2007 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -28.4 | 123.4% |
| 2021 | -12.7 | -74.07% |
| 2020 | -49.0 | -118.89% |
| 2019 | 259 | 2908.08% |
| 2018 | 8.62 | -404.28% |
| 2017 | -2.83 | 72.27% |
| 2016 | -1.64 | -60.6% |
| 2015 | -4.17 | -38.21% |
| 2014 | -6.76 | 76.96% |
| 2013 | -3.82 | -17.58% |
| 2012 | -4.63 | 155.77% |
| 2011 | -1.81 | -61.02% |
| 2010 | -4.65 | -10.16% |
| 2009 | -5.17 | 13.79% |
| 2008 | -4.55 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 | -0.9953 | -97.69% | 🇺🇸 USA |
 | -5.24 | -87.82% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.